SIRT3 and cardiac hypertrophy: SIRT3 interacts with FOXO3a to activate antioxidant genes, such as MnSOD and catalase, the products of which can reduce the level of ROS and positively affect disorders such as interstitial fibrosis and cardiac hypertrophy (Sundaresan et al., 2009).